Mechanisms for modulating anoikis resistance in cancer and the relevance of metabolic reprogramming

FO Adeshakin, AO Adeshakin, LO Afolabi, D Yan… - Frontiers in …, 2021 - frontiersin.org
The attachment of cells to the extracellular matrix (ECM) is the hallmark of structure–function
stability and well-being. ECM detachment in localized tumors precedes abnormal …

[HTML][HTML] NF-κB inhibitors gifted by nature: The anticancer promise of polyphenol compounds

C Guan, X Zhou, H Li, X Ma, J Zhuang - Biomedicine & Pharmacotherapy, 2022 - Elsevier
Polyphenol compounds are natural antioxidants, which are rich in anti-inflammatory and
antioxidant components. They have a wide range of medicinal benefits that are believed to …

Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistance

L Fouassier, M Marzioni, MB Afonso… - Liver …, 2019 - Wiley Online Library
Cholangiocarcinoma (CCA) is a deadly disease. While surgery may attain cure in a minor
fraction of cases, therapeutic options in either the adjuvant or advanced setting are limited …

Metformin: the answer to cancer in a flower? Current knowledge and future prospects of metformin as an anti-cancer agent in breast cancer

SM Samuel, E Varghese, P Kubatka, CR Triggle… - Biomolecules, 2019 - mdpi.com
Interest has grown in studying the possible use of well-known anti-diabetic drugs as anti-
cancer agents individually or in combination with, frequently used, chemotherapeutic agents …

STAT3 as a therapeutic target in the metformin-related treatment

W Zhang, D Li, B Li, X Chu, B Kong - International Immunopharmacology, 2023 - Elsevier
Signal transducers and activators of transcription 3 (STAT3) signaling plays an important
role in mediating tumor progression, inflammation, cardiovascular disease, and other …

Metformin: metabolic rewiring faces tumor heterogeneity

M Cioce, C Pulito, S Strano, G Blandino, VM Fazio - Cells, 2020 - mdpi.com
Tumor heterogeneity impinges on all the aspects of tumor history, from onset to metastasis
and relapse. It is growingly recognized as a propelling force for tumor adaptation to …

Regulators and mechanisms of anoikis in triple-negative breast cancer (TNBC): A review

A Tajbakhsh, M Rivandi, S Abedini, A Pasdar… - Critical reviews in …, 2019 - Elsevier
Metastasis leads to poor prognosis and reduced disease-free survival in breast cancer
patients, particularly in those with triple-negative breast cancer (TNBC) which is resistant to …

Research progress of metformin in the treatment of liver fibrosis

A Zhang, F Qian, Y Li, B Li, F Yang, C Hu, W Sun… - International …, 2023 - Elsevier
Liver fibrosis is a disease with significant morbidity and mortality. It is a chronic pathological
process characterized by an imbalance of extracellular matrix production and degradation in …

Curcumin analog WZ26 induces ROS and cell death via inhibition of STAT3 in cholangiocarcinoma

M Chen, C Qian, B Jin, C Hu, L Zhang… - Cancer Biology & …, 2023 - Taylor & Francis
Cholangiocarcinoma (CCA) is an aggressive biliary epithelial tumor with limited therapeutic
options and poor prognosis. Curcumin is a promising active natural compound with several …

Repurposing metformin for cancer treatment: a great challenge of a promising drug

C Saengboonmee, T Sanlung… - Anticancer …, 2021 - ar.iiarjournals.org
The safety windows and toxicity of clinically available known drugs allow drug repurposing
to be a popular treatment strategy for several diseases, including cancers. Several common …